In this prospective cohort study involving 89 DLBCL patients, we investigated the impact of PB- and BM-CD11b+CX3CR1+ monocytes on survival outcomes in patients with newly diagnosed DLBCL treated with R-CHOP immunochemotherapy. Here, ITGAM is linked to diffuse large B-cell lymphoma.